COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have recently been diagnosed with a complication called GVHD (a condition where donated cells react against the body after a transplant) and have just started taking steroid medication for it for the first time since your transplant
- You received a stem cell transplant from a donor at Dana-Farber Cancer Institute
- Your doctor has confirmed it is safe for you to do moderate to vigorous exercise
- You are able to speak English
- You currently do less than 60 minutes of organised/structured exercise per week
- You are willing and able to travel to Dana-Farber Cancer Institute for required study visits
- You are able to understand and sign a written consent form agreeing to take part
Who may not be able to join:
- You are planning to be admitted to hospital within the next 13 weeks at the time of joining the study
- You did not join the study within 14 days of starting your steroid treatment
- You have a pre-existing condition affecting your muscles, joints, heart, or lungs
- You have an illness that is not well controlled, such as an active infection, uncontrolled diabetes, high blood pressure, or a thyroid condition
- You are currently receiving other experimental treatments, or are undergoing chemotherapy, biological therapy, or radiation therapy
- You have another active cancer
- You already do more than 60 minutes of organised/structured exercise per week
- You are unable to travel to Dana-Farber Cancer Institute for the required study visits
- The study team has concerns that you may not be able to safely follow the study's monitoring requirements (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christina Dieli-Conwright, Dana-Farber Cancer Institute
Phone: 617-582-8321
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients completing the exercise intervention sessions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.